Search results for " facility"
Article
CMOs Continue to Improve Overall Biomanufacturing Performance
Probably by no coincidence, 7 in 10 CMOs plan to increase their spending on new facility construction this year, by an average amount of 11.3%.
The next biggest culprit in projected capacity…
Article
Breakthrough Drugs Raise Development and Production Challenges
Manufacturers need to decide dosage form and methods validation strategies much sooner, he said at the CMC workshop, and should “plan for the unexpected,” such as facility qualification failures and c…
Article
Quality Systems Key to Lifecycle Drug Management
PACMPs may be appropriate for certain changes to biological products, such as adding a new cell-culture facility, and should be most useful for drugs developed using QbD principles, Robert commented. …
Article
Optimizing Resin Performance with Disposable Chromatography Solutions
…ost, not only of the chromatography media used, but also of the labor for packing, utilities, use of facility time, the potential cost of a repack, and the additional costs of potential contamination…
Article
A Q&A With Parrish Galliher About Adopting Single-Use Systems
This week, Process Development Forum speaks with Parrish Galliher, Chief Technology Officer Upstream at Cytiva, about trends within the bioprocess area.
What’s one of the biggest t…
Article
Novel Vaccine Technologies Meet the Need for Pandemic and Therapeutic Solutions
The company received the 2013 Facility of the Year Award issued by the International Society for Pharmaceutical Engineering (ISPE) for its flu cell-culture technology, which it has implemented at a ne…
Article
Biopharma Outsourcing Activities Update
Outsourcing activity remains strong and unlikely to abate, especially in more traditional areas.
Over the past 11 years, BioPlan’s annual report and survey of biopharmaceutical manufacturing ha…
Article
The Future of Biopharma
What the industry's future holds and what needs to be done to get there.
The biopharmaceutical industry continues to evolve with expectations of a positive future. Much of this anticipation …
Article
Addressing the Challenges in Downstream Processing Today and Tomorrow
…, high-throughput screening (HTS) tools, and reduction of the number of unit operations to help with facility fit. In the future, mAbs may represent a smaller percentage of the pipeline as portfolios…
Article
Report from the 12th Plasma Product Biotechnology Forum
With moderate investment Biopharma Plasma have constructed a fractionation facility to process up to one million liters of plasma plus eight modern plasma collection centers. Most impressively, they h…